Kadidia Dienta joins Gresh and Fauria along with Dr. Reid Merryman. Kadidia discusses her battle with lymphoma cancer that begin in July 2020. Kadidia’s treatment included chemotherapy, CAR T therapy, and after two relapses with cancer, she is currently participating in a clinical trial that shows promise. 

Dr. Merryman is an attending physician in the Lymphoma Program at Dana-Farber Cancer Institute. His research focuses on the development of immune-based therapies for patients with lymphoma.

Kadidia Dienta joins Gresh and Fauria along with Dr. Reid Merryman. Kadidia discusses her battle with lymphoma cancer that begin in July 2020. Kadidia’s treatment included chemotherapy, CAR T therapy, and after two relapses with cancer, she is currently participating in a clinical trial that shows promise. 
Dr. Merryman is an attending physician in the Lymphoma Program at Dana-Farber Cancer Institute. His research focuses on the development of immune-based therapies for patients with lymphoma.

Hear stories of hope and inspiration for a cancer-free future from the annual WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance.

Hear stories of hope and inspiration for a cancer-free future from the annual WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance.

Advertisement